GlassScriptPhysician profile
Mojgan Khatami
NPI 1770555070
$2,025.79
in general payments reported to CMS, 2019-2025
17 companies · $87.34 in 2025
The $87.34 reported for 2025 was less than what a typical Gynecology provider received nationally (typical 2025 total: $162).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $235 · 2020: $387 · 2021: $672 · 2022: $272 · 2023: $238 · 2024: $134 · 2025: $87.34.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $459.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $459.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $699.92 | 2019-2025 | |
| Mayne Pharma Commercial LLC | $487.95 | 2021-2025 | |
| Evofem Biosciences, INC. | $208.02 | 2021-2025 | Phexxi, Solosec, Phexx |
| Millicent US INC | $113.83 | 2019-2020 | |
| Therapeuticsmd, INC. | $87.90 | 2019-2021 | |
| Astellas Pharma US INC | $75.42 | 2019-2023 | Myrbetriq |
| Organon LLC | $70.98 | 2021-2024 | Nexplanon |
| Exeltis, USA INC. | $66.04 | 2019-2022 | |
| Agile Therapeutics, INC. | $41.60 | 2021-2022 | |
| Ascend Therapeutics US, LLC | $32.40 | 2021-2024 | |
| Mycovia Pharmaceuticals, INC. | $29.61 | 2023 | Vivjoa |
| Mylan Pharmaceuticals INC. | $25.17 | 2021 | |
| Avion Pharmaceuticals | $23.37 | 2020-2022 | |
| Vertical Pharmaceuticals, LLC | $19.61 | 2019 | |
| Amag Pharmaceuticals, INC. | $17.13 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lupin INC. | $13.42 | 2020 | |
| Allergan, INC. | $13.42 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mojgan Khatami listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.